These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 19258583)
1. 5-Alpha reductase inhibitors and risk of hip fracture. Bollu M; Marte-Grau AC; Bobba RK JAMA; 2009 Mar; 301(9):935; author reply 935. PubMed ID: 19258583 [No Abstract] [Full Text] [Related]
2. Association between 5-alpha reductase inhibition and risk of hip fracture. Jacobsen SJ; Cheetham TC; Haque R; Shi JM; Loo RK JAMA; 2008 Oct; 300(14):1660-4. PubMed ID: 18840839 [TBL] [Abstract][Full Text] [Related]
3. Finasteride in benign prostatic hyperplasia. Wysowski DK; Farinas E N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15044649 [No Abstract] [Full Text] [Related]
4. By the way, doctor. Finasteride has been prescribed for my BPH. I think that the most frequent side effect is erectile dysfunction or loss of sexual desire. Would Levita or a similar drug (like Viagra or Cialis) overcome the side effects of finasteride? O'Leary M Harv Health Lett; 2009 Jun; 34(8):8. PubMed ID: 19623735 [No Abstract] [Full Text] [Related]
6. Prostate cancer risk among users of finasteride and alpha-blockers - a population based case-control study. Murtola TJ; Tammela TL; Määttänen L; Hakama M; Auvinen A Eur J Cancer; 2007 Mar; 43(4):775-81. PubMed ID: 17251005 [TBL] [Abstract][Full Text] [Related]
9. On call. I have read several news reports that claim finasteride, which I take for my prostate problem, can cause permanent impotence. Should I be concerned? Kormos W Harv Mens Health Watch; 2013 Jan; 17(6):2. PubMed ID: 23807950 [No Abstract] [Full Text] [Related]
10. 5 alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia. Stoner E Recent Prog Horm Res; 1994; 49():285-92. PubMed ID: 7511828 [No Abstract] [Full Text] [Related]
11. [The effect of 5-alpha-reductase inhibitors on benign prostatic hyperplasia]. Djavan B; McConnell J Wien Med Wochenschr; 1996; 146(8):165-8. PubMed ID: 8767401 [TBL] [Abstract][Full Text] [Related]
12. [How effective is finasteride?]. Krome S Dtsch Med Wochenschr; 2011 Feb; 136(8):354. PubMed ID: 21348003 [No Abstract] [Full Text] [Related]
13. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. McConnell JD; Roehrborn CG; Bautista OM; Andriole GL; Dixon CM; Kusek JW; Lepor H; McVary KT; Nyberg LM; Clarke HS; Crawford ED; Diokno A; Foley JP; Foster HE; Jacobs SC; Kaplan SA; Kreder KJ; Lieber MM; Lucia MS; Miller GJ; Menon M; Milam DF; Ramsdell JW; Schenkman NS; Slawin KM; Smith JA; N Engl J Med; 2003 Dec; 349(25):2387-98. PubMed ID: 14681504 [TBL] [Abstract][Full Text] [Related]
14. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine]. Loran OB; Pushkar' DIu; Rasner PI Urologiia; 2002; (1):19-22. PubMed ID: 11877966 [TBL] [Abstract][Full Text] [Related]
15. [Drugs against symptomatic, benign prostatic hyperplasia]. Johansen TE Tidsskr Nor Laegeforen; 2002 Oct; 122(26):2544-5. PubMed ID: 12522881 [No Abstract] [Full Text] [Related]
16. Effect of 5α-Reductase Inhibitor Use on Mortality From Prostate Cancer. Figg WD; Thompson IM JAMA Oncol; 2015 Jun; 1(3):321-2. PubMed ID: 26181178 [No Abstract] [Full Text] [Related]
17. Finasteride for BPH. Johnson KH; Casey CM J Fam Pract; 1998 Jun; 46(6):455-6. PubMed ID: 9638104 [No Abstract] [Full Text] [Related]